- Home
- EVI vs CADL Comparison
EVI vs CADL Comparison
Compare EVI & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EVI | CADL |
|---|---|---|
| Founded | 1959 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 353.9M | 339.8M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | EVI | CADL |
|---|---|---|
| Price | $22.30 | $5.29 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 7 |
| Target Price | ★ $40.00 | $19.43 |
| AVG Volume (30 Days) | 18.0K | ★ 763.1K |
| Earning Date | 11-10-2025 | 11-13-2025 |
| Dividend Yield | ★ 1.55% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.39 | N/A |
| Revenue | ★ $404,474,000.00 | N/A |
| Revenue This Year | $13.65 | N/A |
| Revenue Next Year | $4.49 | N/A |
| P/E Ratio | $54.21 | ★ N/A |
| Revenue Growth | ★ 12.63 | N/A |
| 52 Week Low | $14.99 | $4.25 |
| 52 Week High | $34.82 | $14.60 |
Technical Indicators
Market Signals| Indicator | EVI | CADL |
|---|---|---|
| Relative Strength Index (RSI) | 42.59 | 59.68 |
| Support Level | $19.50 | $4.38 |
| Resistance Level | $22.96 | $4.87 |
| Average True Range (ATR) | 1.28 | 0.29 |
| MACD | 0.27 | 0.11 |
| Stochastic Oscillator | 63.97 | 89.81 |
Price Performance
Historical ComparisonAbout EVI EVI Industries Inc.
EVI Industries Inc through its subsidiaries, is a distributor that sells, leases, and rents commercial, industrial, and vended laundry and dry cleaning equipment and steam and hot water boilers manufactured by others, supplies related replacement parts and accessories, designs and plans turn-key laundry, dry cleaning, and boiler systems, and provides installation and maintenance services to its customers, which include commercial, industrial, institutional, government, and retail customers. These activities are conducted in the United States, Canada, the Caribbean, and Latin America.
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.